Uveitis and Posterior Ophthalmic Manifestations Following the SARS-CoV-2 (COVID-19) Vaccine.

Autor: Patel KG; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA., Hilton T; Texas Retina Associates, Dallas, Texas, USA., Choi RY; Texas Retina Associates, Dallas, Texas, USA., Abbey AM; Texas Retina Associates, Dallas, Texas, USA.
Jazyk: angličtina
Zdroj: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2022 Jul; Vol. 30 (5), pp. 1142-1148. Date of Electronic Publication: 2022 Jun 28.
DOI: 10.1080/09273948.2022.2079533
Abstrakt: Purpose: To present four cases of posterior ophthalmic manifestations associated with a temporal relationship to SARS-CoV-2 vaccination.
Methods: Retrospective case series with a review of clinical findings.
Results: Four patients presented with various posterior ophthalmic findings including uveitis, maculopathy, and optic neuropathy. Each of their clinical courses varied in terms of ophthalmic imaging and exam findings.
Conclusion: The coronavirus disease 2019 (COVID-19) pandemic has ushered in a new wave of challenges to healthcare, epidemiological endeavors, and widespread vaccination efforts. Novel vaccines have been developed for the SARS-CoV-2 virus, including both mRNA and viral vector-based platforms. The ocular manifestations and side effects related to the SARS-CoV-2 vaccine is not well established or understood. There may be an association between vaccination and posterior ophthalmic manifestations.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje